Isabel J. Hildebrandt, Ph.D.

Affiliations: 
2007 University of California, Los Angeles, Los Angeles, CA 
Area:
Pharmacology
Google:
"Isabel Hildebrandt"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Johannes Czernin grad student 2007 UCLA
 (Reproducibility and sensitivity in small animal imaging.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Walter MA, Benz MR, Hildebrandt IJ, et al. (2011) Metabolic imaging allows early prediction of response to vandetanib. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 231-40
Walter MA, Hildebrandt IJ, Hacke K, et al. (2010) Small-animal PET/CT for monitoring the development and response to chemotherapy of thymic lymphoma in Trp53-/- mice. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1285-92
Guo D, Hildebrandt IJ, Prins RM, et al. (2009) The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis. Proceedings of the National Academy of Sciences of the United States of America. 106: 12932-7
Schluep T, Hwang J, Hildebrandt IJ, et al. (2009) Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements. Proceedings of the National Academy of Sciences of the United States of America. 106: 11394-9
Wei LH, Olafsen T, Radu C, et al. (2008) Engineered antibody fragments with infinite affinity as reporter genes for PET imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 1828-35
Wei LH, Su H, Hildebrandt IJ, et al. (2008) Changes in tumor metabolism as readout for Mammalian target of rapamycin kinase inhibition by rapamycin in glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 3416-26
Bartlett DW, Su H, Hildebrandt IJ, et al. (2007) Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proceedings of the National Academy of Sciences of the United States of America. 104: 15549-54
See more...